This function is exclusive for Premium subscribers

  • DATABASE (46)

  • ARTICLES (19)

    • DATABASE (46)
    • ARTICLES (19)

Feedzai is a powerful cloud-based AI tool detecting e-commerce fraud in real-time among trillions of dollars of transactions by the world’s largest corporates.

Shenzhen's cybersecurity startup can detect malicious threats well in advance, with 99% accuracy.

CraiditX uses AI technology and data mining to provide financial institutions with information on risk management, marketing and customer service.  

Ecertic's EADTrust-approved digital identity solutions ensure companies who digitize their business processes also adhere to the latest local regulations. 

Geetest’s behavior-based authentication technology better protects websites from attacks and makes it easier for clients to verify web visitors.

Alias Robotics keeps robots and their components safe with automatically-updating hi-tech immunity chips, compatible with most robotics software, that use bio-inspired AI.

A spellchecker that supports 28 programming languages, Codacy optimizes development efforts, saves hours of work and improves cybersecurity through automated code review.

Trusted by internet finance firms, China’s largest e-contracting and e-signature platform allows for faster and more secure transactions at a lower cost.

The hassle of remembering passwords is a thing of the past thanks to Secken, China’s only biometric authentication company offering safe and easy Internet logins.

The venture capital arm of Cisco was established in 1993 in San Francisco and currently has a US$2bn active portfolio. Each year, it invests between US$200-300m from Series A rounds to later investment stages. Cisco Investments has more than 120 companies in its portfolio. It has managed multiple exits and acquisitions, most recently by purchasing customer analytics technology CloudCherry for an undisclosed sum in August 2019. Cisco Investment's recent portfolio investments include healthcare platform Luma Health's US$16m Series B round and big data cybersecurity startup Exabeam's US$75m Series E round.

Caffeinated Capital is a San Francisco-based venture capital firm founded by Raymond Tonsing, founded in 2009. Since 2016, it has launched three funds, investing a total US$242 million in 60 companies, including five as the lead investor. It has seen a number of prominent exits including Parse, WePay and Appurify and was the lead investor in Series B rounds for Sapho and Airtable, besides MemSQL's Series C funding. Its recent investments include in Opendoor's Series E round and in Triplebyte's Series B and SentiLink's Series A rounds. Healthcare, fintech and cryptosecurity are key investment areas. 

Founded in 2006 and renamed in 2010, Floodgate Fund is a venture capital firm focused on early-stage investment in technology sectors.

Frontline Ventures is a London-based VC firm that typically invests in early-stage B2B companies with the bulk of funding going toward European companies seeking a U.S. expansion. The current Fund II, worth €60 million, closed in 2016 and they are looking to make investments of between €200,000 and €3 million each.

Bonsai VC invests in Spanish startups with global ambitions and mobile-focused business models. The founders and managers, including Javier Cebrián Monereo, Javier Cebrián Sagarriga, Luis González Buendía and Rafael Gutierrez de Calderón; own approximately 60% of the VC share capital.

Finch Capital is formerly known as Orange Growth Capital. Operating from their offices in Amsterdam, London and Singapore, they invest in European and Southeast Asian early-stage companies that have already generated revenue. They are "thematic investors", focusing on enabling technological innovation for the finance services sector.

Your payment was not successful.

Please make sure you have entered your payment details correctly. Or try again in a few moments.

small logo

The discount code you entered is invalid

Please make sure you have entered your discount code correctly. Or try again in a few moments.

Download successful.

Your sample has been sent. Please check your email.

By accessing and using and all pages within the domain (the “Website”), You accept and agree to have read, understood, accepted and agreed to be bound by the Terms of Use and Privacy Policy in full. If you disagree with all or any part of these Terms of Use and Privacy Policy, please do not use or continue any further use of this website. You acknowledge that you are aware that this Website contains an archive of existing content as at 31 December 2021 and is not being actively managed. We are under no obligation to update the content on this Website and, accordingly, no new content or articles will be posted to the Website after 31 December 2021.